US 8759006
PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
granted A61KA61K2039/505A61K31/704
Quick answer
US patent 8759006 (PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia) held by The Regents of the University of California expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K31/704, A61K38/00, A61K39/395